[go: up one dir, main page]

WO1991013062A3 - Derives de 1-(alkoxy-iminoalkyl)imidazole substitues - Google Patents

Derives de 1-(alkoxy-iminoalkyl)imidazole substitues Download PDF

Info

Publication number
WO1991013062A3
WO1991013062A3 PCT/EP1991/000351 EP9100351W WO9113062A3 WO 1991013062 A3 WO1991013062 A3 WO 1991013062A3 EP 9100351 W EP9100351 W EP 9100351W WO 9113062 A3 WO9113062 A3 WO 9113062A3
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
optionally substituted
alkoxy
hydrogen
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1991/000351
Other languages
English (en)
Other versions
WO1991013062A2 (fr
Inventor
Paolo Cozzi
Maria Menichincheri
Arsenia Rossi
Corrado Ferti
Patricia Salvati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909004347A external-priority patent/GB9004347D0/en
Priority claimed from GB909027551A external-priority patent/GB9027551D0/en
Priority to EP91904730A priority Critical patent/EP0469125B1/fr
Priority to KR1019910701434A priority patent/KR920701168A/ko
Priority to AU73043/91A priority patent/AU644632B2/en
Priority to FI915056A priority patent/FI915056A7/fi
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Priority to DE69107137T priority patent/DE69107137T2/de
Priority to CA002053256A priority patent/CA2053256A1/fr
Priority to US07/768,568 priority patent/US5280033A/en
Publication of WO1991013062A2 publication Critical patent/WO1991013062A2/fr
Publication of WO1991013062A3 publication Critical patent/WO1991013062A3/fr
Anticipated expiration legal-status Critical
Priority to GR950400950T priority patent/GR3015820T3/el
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Luminescent Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Epoxy Resins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Dérivés de 1-(alkoxy-iminoalkyle)imidazole de formule (I) où R est hydrogène ou C1-C4 alkyle; A est C1-C4 alkylène, substitué facultativement par phényle substitué facultativement par halogène ou trifluorométhyle; R est (a) hydrogène ou un radical d'hydrocarbure C1-C10, (b) un groupe aryle ou aryle-C1-C4, où ledit aryle est substitué facultativement soit par halogène, trihalométhyle, C1-C4 alkyle, C2-C3 alkényle, C2-C6 alkynyle, C1-C4 alkoxy, C1-C4 alkylthio ou C1-C4 alkylsulfonyle ou par C5-C8 alkyle, C4-C8 alkényle, C5-C8 alkoxy, C5-C8 alkylthio ou phényle substitué facultativement par halogène, trihalométhyle ou C1-C4 alkyle; ou (c) un groupe C5-C8 cycloalkyle ou C5-C8 cycloalkyle-C1-C4 alkyle, où ledit cycloalkyle est substitué facultativement par C1-C4 alkyle; T est une chaîne d'hydrocarbure C1-C6 ou de phénylène; X est une liaison, -O-CH2-, -C(R' R'')-, Si(R' R'')-, vinylène ou isopropénylène; chacun de R' et R'' étant hydrogène, fluor ou C1-C4 alkyle; et R2 est -OR3 ou N(R3R4), chacun de R3 et R4 étant hydrogène, C1-C6 alkyle, phényle ou benzyle; et leur sels pharmaceutiquement acceptables. Lesdits dérivés sont utiles dans le traitement d'un état pathologique dû à l'amélioration de la synthèse de thromboxane A2 (TxA2).
PCT/EP1991/000351 1990-02-27 1991-02-26 Derives de 1-(alkoxy-iminoalkyl)imidazole substitues Ceased WO1991013062A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US07/768,568 US5280033A (en) 1990-02-27 1991-02-26 Substituted 1-(alkoxy-iminoalkyl) imidazole derivatives and their use in treating disease related to an enhancement of thromboxane-A2 syntheis
CA002053256A CA2053256A1 (fr) 1990-02-27 1991-02-26 Derives de 1-(alkoxy-iminoalkyl)imidazole a substituant
KR1019910701434A KR920701168A (ko) 1990-02-27 1991-02-26 치환된 1-(알콕시-이미노알킬)이미다졸 유도체
AU73043/91A AU644632B2 (en) 1990-02-27 1991-02-26 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
FI915056A FI915056A7 (fi) 1990-02-27 1991-02-26 Substituoidut 1-(alkoksi-iminoalkyyli)imidatsoli-johdannaiset
EP91904730A EP0469125B1 (fr) 1990-02-27 1991-02-26 Derives de 1-(alkoxy-iminoalkyl)imidazole substitues
DE69107137T DE69107137T2 (de) 1990-02-27 1991-02-26 1-(alkoxy-iminoalkyl)imidazolderivate.
GR950400950T GR3015820T3 (en) 1990-02-27 1995-04-17 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9004347.2 1990-02-27
GB909004347A GB9004347D0 (en) 1990-02-27 1990-02-27 Substituted 1-(alkoxy-iminoalkyl)-imidazole derivatives
GB909027551A GB9027551D0 (en) 1990-12-19 1990-12-19 Carboxy derivatives of substituted 1-(alkoxy-iminoalkyl)imidazole
GB9027551.2 1990-12-19

Publications (2)

Publication Number Publication Date
WO1991013062A2 WO1991013062A2 (fr) 1991-09-05
WO1991013062A3 true WO1991013062A3 (fr) 1991-10-17

Family

ID=26296723

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1991/000351 Ceased WO1991013062A2 (fr) 1990-02-27 1991-02-26 Derives de 1-(alkoxy-iminoalkyl)imidazole substitues

Country Status (19)

Country Link
US (1) US5280033A (fr)
EP (1) EP0469125B1 (fr)
JP (1) JPH04505464A (fr)
KR (1) KR920701168A (fr)
AT (1) ATE117995T1 (fr)
AU (1) AU644632B2 (fr)
CA (1) CA2053256A1 (fr)
DE (1) DE69107137T2 (fr)
DK (1) DK0469125T3 (fr)
ES (1) ES2074263T3 (fr)
FI (1) FI915056A7 (fr)
GR (1) GR3015820T3 (fr)
HU (1) HU209471B (fr)
IE (1) IE67286B1 (fr)
IL (1) IL97144A (fr)
MY (1) MY105343A (fr)
NZ (1) NZ237168A (fr)
PT (1) PT96895A (fr)
WO (1) WO1991013062A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116470D0 (en) * 1991-07-30 1991-09-11 Erba Carlo Spa 2-(imidazol-1-yl)-benzylethylidene-aminoxyalkanoic acid derivatives
GB9302599D0 (en) * 1993-02-10 1993-03-24 Erba Carlo Spa 2-(imadazol-l-yl)-heteroaryl-propylidene-aminoxyalkanoic acid derivatives
GB9315058D0 (en) * 1993-07-20 1993-09-01 Erba Carlo Spa 2-(imidazol-1-yl)benzylethylidene-aminooxylkyl-hydroxamic acid derivatives
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
WO1999045905A2 (fr) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxie et traitement de la migraine par les inhibiteurs de thromboxane synthetase et/ou les antagonistes de recepteur de thromboxane
CA2518986A1 (fr) * 2003-03-13 2004-09-23 Ono Pharmaceutical Co., Ltd. Composes derives d'imino ether et medicaments renfermant ces composes comme principe actif
CN112574176B (zh) * 2019-09-27 2024-03-15 隆泰申医药科技(南京)有限公司 一种杂芳基类化合物及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028346A1 (fr) * 1979-11-03 1981-05-13 Bayer Ag Ethers trisubstitués de benzyl-oximes, procédé pour leur préparation et leur utilisation comme fongicides
EP0065107A2 (fr) * 1981-04-28 1982-11-24 Bayer Ag Dérivés d'azolylpropyl-oximino, procédé pour leur préparation et leur application comme fongicide et agent de régulation de la croissance des plantes
EP0132771A2 (fr) * 1983-07-22 1985-02-13 Hoechst Aktiengesellschaft Dérivés de 1,2-diaryl-3-azolyl-propane, leur préparation et utilisation dans le traitement des plantes
EP0142653A1 (fr) * 1983-09-22 1985-05-29 Bayer Ag Ethers d'oximes substitués par le groupe azolyle en position 1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4352804A (en) * 1978-07-25 1982-10-05 Acf Chemiefarma Nv Oxime ethers, their preparation and pharmaceutical compositions containing them
EP0034249B1 (fr) * 1980-02-08 1984-10-24 Gruppo Lepetit S.P.A. Dérivés du naphtimidazole et du naphtoxazole, leur préparation et leur utilisation dans des médicaments
DE3413365A1 (de) * 1984-04-09 1985-12-19 Merz + Co GmbH & Co, 6000 Frankfurt Substituierte phenylethylderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3545085A1 (de) * 1985-12-19 1987-07-02 Bayer Ag Substituierte cyclopropyl-oximether

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028346A1 (fr) * 1979-11-03 1981-05-13 Bayer Ag Ethers trisubstitués de benzyl-oximes, procédé pour leur préparation et leur utilisation comme fongicides
EP0065107A2 (fr) * 1981-04-28 1982-11-24 Bayer Ag Dérivés d'azolylpropyl-oximino, procédé pour leur préparation et leur application comme fongicide et agent de régulation de la croissance des plantes
EP0132771A2 (fr) * 1983-07-22 1985-02-13 Hoechst Aktiengesellschaft Dérivés de 1,2-diaryl-3-azolyl-propane, leur préparation et utilisation dans le traitement des plantes
EP0142653A1 (fr) * 1983-09-22 1985-05-29 Bayer Ag Ethers d'oximes substitués par le groupe azolyle en position 1

Also Published As

Publication number Publication date
HU209471B (en) 1994-06-28
HUT59910A (en) 1992-07-28
US5280033A (en) 1994-01-18
EP0469125B1 (fr) 1995-02-01
IE910647A1 (en) 1991-08-28
JPH04505464A (ja) 1992-09-24
IL97144A (en) 1994-11-28
PT96895A (pt) 1991-10-31
HU913625D0 (en) 1992-03-30
CA2053256A1 (fr) 1991-08-28
KR920701168A (ko) 1992-08-11
DK0469125T3 (da) 1995-03-27
DE69107137D1 (de) 1995-03-16
IL97144A0 (en) 1992-05-25
DE69107137T2 (de) 1995-06-01
AU644632B2 (en) 1993-12-16
EP0469125A1 (fr) 1992-02-05
ES2074263T3 (es) 1995-09-01
NZ237168A (en) 1992-07-28
IE67286B1 (en) 1996-03-20
ATE117995T1 (de) 1995-02-15
FI915056A0 (fi) 1991-10-25
WO1991013062A2 (fr) 1991-09-05
GR3015820T3 (en) 1995-07-31
FI915056A7 (fi) 1991-10-25
MY105343A (en) 1994-09-30
AU7304391A (en) 1991-09-18

Similar Documents

Publication Publication Date Title
CA2290992A1 (fr) Derives d'(imidazol-5-yl)methyle-2-quinolinone comme inhibiteurs de la proliferation des cellules des muscles lisses
CA2312935A1 (fr) Derives d'acide hydroxamique utilises comme inhibiteurs de metalloproteases matricielles
DK0560177T3 (da) Imidazol-derivater med biphenylsulfonylurinstof- eller biphenylsulfonylurethan-sidekæde, fremgangsmåder til deres fremstilling og deres anvendelse.
DE60034785D1 (en) 1-(4-sulfamylphenyl)-3-trifluormethyl-5-aryl-2-pyrazoline als cyclooxygenase-2 inhibitoren
WO2001009103A3 (fr) Agents antiproliferatifs imidazole
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
CA2371012A1 (fr) Imidazoles 4-(1h-pyrol-1-yl)
DE60025848D1 (en) Pyrimidin-derivate als selective inhibitoren von cox-2
EP1184373A4 (fr) Composes tricycliques
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
MX9708147A (es) Compuestos de bencimidazol y su uso como moduladores del complejo receptor de gabaa.
DK0708778T3 (da) Derivater af imidazol(1,2-a)pyrazin-4-on, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
WO1991013062A3 (fr) Derives de 1-(alkoxy-iminoalkyl)imidazole substitues
ATE177096T1 (de) 4-substituierte 1,2,4-triazolderivate
NO20022232L (no) Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII
NO20001515L (no) Vitronektin reseptor-antagonist
MY131096A (en) N-imidazolyl derivatives of substituted indole.
CA2134077A1 (fr) 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines servant de 5ht2-antagonistes de la serotonine, leur mode d'obtention et leur usage therapeutique
ATE172193T1 (de) Piperazinderivate
DK0630367T3 (da) Hidtil ukendte arylindazoler og deres anvendelse som herbicider
DE69525633D1 (de) Chinoxalinderivate und ihre therapeutische verwendbarkeit
NZ501785A (en) 4-(3,4-dihydro-2-naphthylmethyl)- or 4-(2H-3-chromenylmethyl)-4,5-dihydro-1H-imidazole derivatives
EP0889034A4 (fr) Derives d'aminopyridine
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
NO934227L (no) Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI HU JP KR SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI HU JP KR SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991904730

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2053256

Country of ref document: CA

Ref document number: 915056

Country of ref document: FI

WWP Wipo information: published in national office

Ref document number: 1991904730

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991904730

Country of ref document: EP